Keyphrases
AMP-activated Protein Kinase
100%
Glucagon-like
100%
Hepatic Lipogenesis
100%
Dipeptidyl peptidase-4 (DPP-4)
46%
Hepatic Fat
23%
Fat Metabolism
23%
Liver
15%
Lipogenesis
15%
Hepatocytes
15%
Inflammatory Cytokines
7%
Mechanism of Action
7%
Inhibitory Effect
7%
Phosphorylation
7%
Signal Transduction
7%
Mitogen-activated Protein Kinase
7%
Insulin Secretion
7%
Glucose Metabolism
7%
Non-alcoholic Fatty Liver Disease (NAFLD)
7%
Primary Hepatocytes
7%
Dominant Negative
7%
In Vitro Study
7%
High-fat Diet
7%
Insulin Sensitivity
7%
Novel Therapies
7%
Inflammatory Response
7%
Hepatic Lipid Accumulation
7%
Fatty Acid Oxidation
7%
Hepatic Insulin Sensitivity
7%
Hyperinsulinemic-euglycemic Clamp
7%
Carnitine Palmitoyltransferase 1A (CPT1A)
7%
Profibrotic Cytokines
7%
Hemolymph Glucose
7%
Lipolytic Enzymes
7%
AMPK Phosphorylation
7%
Gut Peptides
7%
AMPK Pathway
7%
Lipogenic
7%
Biochemistry, Genetics and Molecular Biology
Lipogenesis
100%
AMP-activated Protein Kinase
100%
Glucagon-Like Peptide-1
100%
Dipeptidyl Peptidase-4
46%
Enzyme
23%
Lipid Metabolism
23%
Hepatocyte
23%
Cyclic Adenosine Monophosphate
15%
Insulin Sensitivity
15%
Signal Transduction
7%
Protein Kinases
7%
Glucose Metabolism
7%
Insulin Release
7%
Triglyceride
7%
Cytokine
7%
Upregulation
7%
Downregulation
7%
In Vitro Study
7%
Lipid Storage
7%
Beta Oxidation
7%
Carnitine Palmitoyltransferase I
7%
Pharmacology, Toxicology and Pharmaceutical Science
Glucagon-Like Peptide-1
100%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
100%
Dipeptidyl Peptidase IV
46%
Triacylglycerol
7%
Nonalcoholic Fatty Liver
7%
Cytokine
7%
Fatty Acid
7%
Protein Kinases
7%
Carnitine Palmitoyltransferase I
7%